medicines
TPP 11 negotiators have agreed to suspend controversial clauses on medicine monopolies and some governments want to renegotiate other clauses, vindicating public interest group concerns
Officials from 11 of the 12 countries that committed to the Trans-Pacific Partnership (TPP) trade deal are meeting in Sydney for talks to re-energize the stalled agreement and discuss amendmends to the pact following the withdrawal of the US.
Stronger intellectual property protection would benefit the US in return for no concessions, civil society groups tell TPP11 Ministers
Through the KORUS revision, the US is openly seeking to bridge its trade deficit with Korea by renegotiating specific terms for individual product categories.
Former diplomat says the EU’s insistence on opening up on wine imports from France and automobile imports from Germany have held up the EU-India FTA negotiations.
At RCEP negotiations held in India, intellectual property rights issues in medicine remain contentious
A battle over the length of data protection for biologic medicine appears to be shaping up in the NAFTA negotiations in a replay of an issue that helped block the Trans-Pacific Partnership from becoming law.
Loon Gangte is an Indian activist living with HIV and hepatitis C, founder of the Delhi Network of Positive People.
However, the key issues holding the final text of these negotiations don’t seem to be getting resolved.
The negotiator’s comments were non-committal but indicated that for now, the RCEP talks have not yet moved decisively into a TRIPS-plus scenario.
Officials from ASEAN member states and other countries meeting in India this week for negotiations on the Regional Comprehensive Economic Partnership (RCEP) should take steps to ensure that the trade deal safeguards human rights, Southeast Asian lawmakers said today.
Trade agreements between countries have a perceivable impact on access to medicines as a result of changes in patent and other national laws in different countries.
The cool reasoning of the Canadian Supreme Court does not acknowledge or reference “external” pressures or the Eli Lilly v. Canada ISDS case. However, courts do not decide cases in a vacuum. This case seems to have been decided in a pressure cooker.
The ’No RCEP’ campaign urges governments to consider the adverse impact of the mega free trade agreement
Goal of implementing most of CETA this summer slips farther from reach.
In the recent “RCEP 18th Round of Talks,” members of civil society organizations and social movements presented their positions vis-à-vis the RCEP.
Through this deal, Swiss pharmaceutical corporations are working to erode India’s ability to produce and supply generic medicines for people across the developing world.
RCEP negotiations have been highly conspiratorial and undemocratic, with all 18 rounds of trade discussions held in secret and no reports shared with the public
The RCEP will only further marginalize women
#NoRCEP week of actions at the 18th TNC Meeting of the Regional Comprehensive Economic Partnership
